Clinical Trials Directory

Trials / Completed

CompletedNCT02021136

Efficacy and Safety of Rebel Reliever Brace in Patients With Symptomatic Medial Knee Osteoarthritis

Efficacy and Safety of Rebel Reliever Brace in Medial Femorotibial Knee Osteoarthritis. Phase 3, Multicenters, Randomised and Controlled Study With 2 Parallel Groups.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Thuasne · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the superiority of Rebel Reliever® knee brace + standard treatment versus standard treatment alone in terms of last 24-hour pain relief after 6 weeks. in patients with medial knee osteoarthritis.

Detailed description

The main criteria is the evaluation of global knee pain during the last 24 hours at D 49 after the inclusion. The response to the treatment will be evaluated during the inclusion visit (V1/D0) and after 6 weeks of treatment, during the following visit (V3/D49). The level of the global pain of the patient during the last 24 hours will be collected by investigators with a VAS (0 mm = no pain ; 100mm = maximun pain) at each visit.

Conditions

Interventions

TypeNameDescription
DEVICERebel RelieverRebel Reliever knee brace + usual antalgic treatment + physical exercises recommendations
OTHERControlUsual antalgic treatment + physical exercises recommendations

Timeline

Start date
2013-10-01
Primary completion
2016-07-01
Completion
2016-09-01
First posted
2013-12-27
Last updated
2016-12-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02021136. Inclusion in this directory is not an endorsement.